Cost-effectiveness analysis of quadrivalent influenza vaccine versus trivalent influenza vaccine for elderly in Hong Kong.
about
Unremarked or Unperformed? Systematic Review on Reporting of Validation Efforts of Health Economic Decision Models in Seasonal Influenza and Early Breast CancerHospitalization Incidence, Mortality, and Seasonality of Common Respiratory Viruses Over a Period of 15 Years in a Developed Subtropical CityMolecular Characteristics of Influenza Virus Type B Lineages Circulating in Poland.Seasonal influenza vaccination for children in Thailand: a cost-effectiveness analysisAn Assessment of the Expected Cost-Effectiveness of Quadrivalent Influenza Vaccines in Ontario, Canada Using a Static ModelAssessment of potential public health impact of a quadrivalent inactivated influenza vaccine in Thailand.Epidemiology of influenza B in Australia: 2001-2014 influenza seasons.Cost-effectiveness of seasonal quadrivalent versus trivalent influenza vaccination in the United States: A dynamic transmission modeling approachFluarix quadrivalent vaccine for influenza.A systematic review of the health economic consequences of quadrivalent influenza vaccination.A review of the value of quadrivalent influenza vaccines and their potential contribution to influenza control.Cost-effectiveness of molecular point-of-care testing for influenza viruses in elderly patients at ambulatory care setting.Cost-effectiveness analysis of quadrivalent versus trivalent influenza vaccine in Taiwan: A lifetime multi-cohort modelEffects of influenza immunization on pneumonia in the elderly.Complementary and alternative medicine in alliance with conventional medicine for influenza therapeutics and prevention
P2860
Q26748855-597CE9E0-8B55-47A4-8AE7-3234CF1B6855Q30202041-C7C93DFD-0E97-4A82-9A25-072FD4AD3DF7Q30383963-49E726A2-4EE5-4663-96A0-25320BE22164Q35642206-5239C4E4-C25B-480E-8237-52EDC9B11F19Q35723417-CD74D2E1-97DC-41AF-AE13-095DBD40902AQ36748191-798F6B68-17A1-4ED0-8078-26236AF8578FQ37638402-C5DFF02B-B1E5-42ED-AB91-71CE5A08A159Q37713755-3B8057F3-F7FB-413D-AABC-4D38C3A006A9Q38534169-848E8CB4-91A4-4390-955A-535B355E0CCEQ38671179-64BE5DFB-0E8D-42D5-A684-C1231AA9BF76Q39322780-77833AEB-78EA-4430-8440-122C79086B99Q40105670-6BDE5C2F-ADDC-4CCF-BA60-CA079C3FFE6FQ40582993-61B88952-0163-4499-A972-708CCDE9F1B7Q47581064-F15B4B59-CC18-44E6-BD45-EBC9FA419F58Q56748544-DC9F283A-7E30-4E69-AE4B-8187A4960C6B
P2860
Cost-effectiveness analysis of quadrivalent influenza vaccine versus trivalent influenza vaccine for elderly in Hong Kong.
description
2014 nî lūn-bûn
@nan
2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Cost-effectiveness analysis of ...... cine for elderly in Hong Kong.
@ast
Cost-effectiveness analysis of ...... cine for elderly in Hong Kong.
@en
Cost-effectiveness analysis of ...... cine for elderly in Hong Kong.
@nl
type
label
Cost-effectiveness analysis of ...... cine for elderly in Hong Kong.
@ast
Cost-effectiveness analysis of ...... cine for elderly in Hong Kong.
@en
Cost-effectiveness analysis of ...... cine for elderly in Hong Kong.
@nl
prefLabel
Cost-effectiveness analysis of ...... cine for elderly in Hong Kong.
@ast
Cost-effectiveness analysis of ...... cine for elderly in Hong Kong.
@en
Cost-effectiveness analysis of ...... cine for elderly in Hong Kong.
@nl
P2093
P2860
P50
P1476
Cost-effectiveness analysis of ...... ccine for elderly in Hong Kong
@en
P2093
Joyce H S You
Paul K S Chan
Wai-kit Ming
P2860
P2888
P356
10.1186/S12879-014-0618-9
P577
2014-11-25T00:00:00Z
P5875
P6179
1011056850